Burry Discloses Puts on Nvidia and Palantir After Bubble Warning

Michael Burry's Scion Asset Management has disclosed new positions via 13F regulatory filings, revealing bearish put options on Nvidia Corp. and Palantir Technologies Inc., a move that follows his recent public warnings about market exuberance. The filings also indicated bullish call options on Halliburton Co. and Pfizer Inc., providing insight into the hedge fund manager's current market outlook.

Analysis

Michael Burry's Scion Asset Management has strategically positioned itself with bearish put options on Nvidia Corp. (NVDA) and Palantir Technologies Inc. (PLTR), as revealed in recent 13F regulatory filings. This move closely follows Burry's public warnings about market exuberance, signaling a high-conviction bet against specific high-valuation technology names. The general sentiment associated with this disclosure is moderately negative (-0.4), reflecting a bearish outlook on these particular assets.

Concurrently, the filings also disclosed bullish call options on Halliburton Co. (HAL) and Pfizer Inc. (PFE). This indicates a nuanced portfolio strategy, potentially rotating capital towards perceived value or defensive sectors while expressing skepticism about certain growth stocks. Per-ticker sentiment for NVDA and PLTR is notably negative (-0.6), contrasting with positive sentiment for HAL and PFE (+0.6).

Burry's reputation, stemming from his 2008 housing market bet, lends significant weight to these disclosures, which carry a market impact score of 0.45. His actions suggest a belief that current market valuations in parts of the tech sector are unsustainable, while identifying potential upside in other, perhaps less-hyped, industries.

Key Decisions for Investors

• Investors should closely monitor the performance of Nvidia and Palantir for increased volatility or potential downward pressure, given Burry's high-profile bearish stance.
• It may be prudent to assess the underlying fundamentals and valuations of these technology companies, especially in light of broader market exuberance warnings.
• Consider the potential for sector rotation into value or defensive plays like Halliburton and Pfizer, aligning with Burry's disclosed bullish positions.